Nominations Open for 2018 Saul Hertz, MD, Award

August 10, 2017

The nomination period for the Saul Hertz, MD, Award, which recognizes the lifetime achievement of individuals who have made outstanding contributions to radionuclide therapy, opened August 1 and will close November 1, 2017.

Sponsored by SNMMI's Therapy Center of Excellence, the award is named in honor of Dr. Saul Hertz, a pioneer in the field, who administered a cyclotron-produced I-130 - I-131 mixture as a therapeutic dose to the first human patient with Graves' hyperthyroidism (Graves' Disease) at Massachusetts General Hospital in 1941.

Nominations must be from a member of the Therapy Center of Excellence, and the package must include

  • a letter written on behalf of the nominee stating the individual's qualifications
  • the curriculum vitae of the nominee

Link to more information